DK301775A - - Google Patents

Info

Publication number
DK301775A
DK301775A DK301775A DK301775A DK301775A DK 301775 A DK301775 A DK 301775A DK 301775 A DK301775 A DK 301775A DK 301775 A DK301775 A DK 301775A DK 301775 A DK301775 A DK 301775A
Authority
DK
Denmark
Application number
DK301775A
Other languages
Danish (da)
Other versions
DK140214B (da
DK140214C (de
Inventor
A Soder
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/485,869 external-priority patent/US4108995A/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK301775A publication Critical patent/DK301775A/da
Priority to DK169277A priority Critical patent/DK169277A/da
Priority to DK169377A priority patent/DK142790B/da
Publication of DK140214B publication Critical patent/DK140214B/da
Application granted granted Critical
Publication of DK140214C publication Critical patent/DK140214C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
DK301775AA 1974-07-05 1975-07-03 Fremgangsmåde til fremstilling af mono-(hydroxyalkyl)-alkylxanthiner. DK140214B (da)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK169277A DK169277A (da) 1974-07-05 1977-04-15 Fremgangsmade til fremstilling af mono(hydroxyalkyl)-alkylxathiner
DK169377A DK142790B (da) 1974-07-05 1977-04-15 Monoalken-1-yl-alkylxanthiner til anvendelse som mellemprodukter ved fremstilling af hydroxyalkyl-alkylxanthiner.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48587074A 1974-07-05 1974-07-05
US05/485,869 US4108995A (en) 1973-07-11 1974-07-05 Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines

Publications (3)

Publication Number Publication Date
DK301775A true DK301775A (de) 1976-01-06
DK140214B DK140214B (da) 1979-07-09
DK140214C DK140214C (de) 1979-12-03

Family

ID=27048497

Family Applications (1)

Application Number Title Priority Date Filing Date
DK301775AA DK140214B (da) 1974-07-05 1975-07-03 Fremgangsmåde til fremstilling af mono-(hydroxyalkyl)-alkylxanthiner.

Country Status (14)

Country Link
JP (1) JPS5250800B2 (de)
AR (1) AR210330A1 (de)
AT (1) AT339917B (de)
CA (1) CA1062710A (de)
CH (2) CH622519A5 (de)
DK (1) DK140214B (de)
ES (1) ES439141A1 (de)
FI (1) FI59249C (de)
FR (1) FR2277089A1 (de)
GB (1) GB1500039A (de)
LU (1) LU72897A1 (de)
NL (1) NL166476C (de)
NO (1) NO143224C (de)
SE (2) SE420097B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664568A5 (de) * 1984-01-12 1988-03-15 Sandoz Ag 8-alpha-acylaminoergoline.
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Also Published As

Publication number Publication date
AT339917B (de) 1977-11-10
SE427183B (sv) 1983-03-14
CH622519A5 (en) 1981-04-15
FI751958A (de) 1976-01-06
AR210330A1 (es) 1977-07-29
SE420097B (sv) 1981-09-14
NL7507976A (nl) 1976-01-07
AU8275575A (en) 1977-01-06
JPS5250800B2 (de) 1977-12-27
DK140214B (da) 1979-07-09
NO143224B (no) 1980-09-22
NL166476B (nl) 1981-03-16
JPS5134194A (de) 1976-03-23
DK140214C (de) 1979-12-03
GB1500039A (en) 1978-02-08
LU72897A1 (de) 1976-05-31
FR2277089A1 (fr) 1976-01-30
SE7507726L (sv) 1976-01-07
CA1062710A (en) 1979-09-18
CH622018A5 (en) 1981-03-13
ES439141A1 (es) 1977-02-16
NO752423L (de) 1976-01-06
NO143224C (no) 1981-01-02
FR2277089B1 (de) 1978-03-17
NL166476C (nl) 1981-08-17
SE7807853L (sv) 1978-07-14
FI59249B (fi) 1981-03-31
ATA517275A (de) 1977-03-15
FI59249C (fi) 1981-07-10

Similar Documents

Publication Publication Date Title
FR2295047B1 (de)
FR2269257B1 (de)
FR2285716B1 (de)
FR2273120B3 (de)
FR2295916B1 (de)
FR2259804A1 (de)
FR2270975B1 (de)
FR2259855A1 (de)
FR2269273B3 (de)
FR2257535B1 (de)
FR2296706B1 (de)
FR2285405B1 (de)
JPS50101531U (de)
JPS50104041A (de)
CH566915A5 (de)
CH17274A4 (de)
DD120437A5 (de)
DD114324A1 (de)
DD109891A1 (de)
CH586770A5 (de)
CH569666A5 (de)
CH569220A5 (de)
CH568539A5 (de)
CH568134A5 (de)
AU480208A (de)

Legal Events

Date Code Title Description
PBP Patent lapsed